Evidence map›Paper›PMID 36916920›Full record

ArticleAntimicrobial agents and chemotherapy2023

Molecular Markers of Sulfadoxine-Pyrimethamine Resistance in Samples from Children with Uncomplicated Plasmodium falciparum at Three Sites in Angola in 2019.

Stefano R Rosillo, Pedro Rafael Dimbu, Ana Luisa M Cândido, Je-Hoon Michael Oh, Carolina Miguel Ferreira, Benjamin Nieto Andrade, Sarah Labuda, Roberta Horth, Julia Kelley, Joana F M Morais and 4 more

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 5 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 3 countries.

Stefano R RosilloMalaria Branch, U.S. Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Pedro Rafael DimbuNational Malaria Control Program, Ministry of Health, Luanda, Angola.
Ana Luisa M CândidoNational Institute of Health Research, Ministry of Health, Luanda, Angola.
Je-Hoon Michael OhMalaria Branch, U.S. Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Carolina Miguel FerreiraPopulation Services International Angola, Luanda, Angola.
Benjamin Nieto AndradePopulation Services International Angola, Luanda, Angola.
Sarah LabudaUnited States President's Malaria Initiative, U.S. Centers for Disease Control and Prevention, Luanda, Angola.
Roberta HorthMalaria Branch, U.S. Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Julia KelleyMalaria Branch, U.S. Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Joana F M MoraisNational Institute of Health Research, Ministry of Health, Luanda, Angola.
Filomeno FortesInstitute of Hygiene and Tropical Medicine, Nova University of Lisbon, Lisbon, Portugal.
José Franco MartinsNational Malaria Control Program, Ministry of Health, Luanda, Angola.
Eldin TalundzicMalaria Branch, U.S. Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Mateusz M PlucińskiMalaria Branch, U.S. Centers for Disease Control and Prevention, Atlanta, Georgia, USA.ORCID 0000-0002-7322-4625
Centers for Disease Control and Prevention · USMinistry of Health · AOUniversity of Lisbon · PT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sulfadoxine-pyrimethamine (SP) is used for prevention of malaria in pregnant women in Angola. We sequenced the Plasmodium falciparum dihydrofolate reductase (

Indexed as

AntimalarialsMalaria, FalciparumAngolaChildDrug CombinationsDrug ResistanceFemaleHumansPlasmodium falciparumPregnancyPyrimethamineSulfadoxineTetrahydrofolate DehydrogenaseAntimalarialsDrug Combinationsfanasil, pyrimethamine drug combinationPyrimethamineSulfadoxineTetrahydrofolate Dehydrogenasedhfrdhpssurveillance

Identifiers

PMID36916920
PMCPMC10112138
OpenAlexW4324129016

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.